Skip to content

Overview

CIDCA donates third batch of emergency medicine worth RMB 35 million to Sri Lanka in October 2022

Commitments (Constant USD, 2023)$4,914,141
Commitment Year2022Country of ActivitySri LankaDirect Recipient Country of IncorporationSri LankaSectorHealthFlow TypeGrant

Status

Project lifecycle

Completion

Pipeline: PledgePipeline: CommitmentImplementationCompletion

Timeline

Key dates

Commitment date
Apr 19, 2022
Start (actual)
Oct 27, 2022
End (actual)
Oct 27, 2022

Stakeholders

Organizations involved in projects and activities supported by financial and in-kind transfers from Chinese government and state-owned entities

Funding agencies

Government Agencies

  • China International Development Cooperation Agency (CIDCA)

Receiving agencies

Government Agencies

  • Government of Sri Lanka

Loan description

CIDCA donates third batch of emergency medicine worth RMB 35 million to Sri Lanka in October 2022

Narrative

Full Description

Project narrative

On October 27, 2022, a batch of medicine worth RMB 35 million arrived in Sri Lanka. The consignment consists of: 15,000 vials of Human Albumin Solution; 330,300 doses of Rabies Vaccine for Human Use (Vero Cell) Freeze-dried; 7,500 vials of 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23); 22,020 vials of Human Immunoglobulin (ph4) for IV use; 170,240 syringes of Recombinant human granulocyte Colony-Stimulating factor injection. This project is part of CIDCA's 500 million RMB humanitarian package to Sri Lanka committed in May 2022 (Record ID#98982). The first batch was donated to Sri Lanka in June 2022 (Record ID#99009); the second batch was donated in September 2022 (Record ID#99245); the third batch was donated in October 2022 (Record ID#100331); the fourth batch was donated in December 2022 (Record ID#98717); the final batch was donated in January 2023 (Record ID#108044).